Recruiting OBSERVATIONAL NCT07160270
This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process
Neuropathy in Waldenström's Macroglobulinemia: Pathophysiology, Prognosis and Treatment
Sponsor: Rigshospitalet, Denmark
Updated 1 time since 2025 Last updated: Aug 29, 2025 Started: May 14, 2025 Primary completion: Dec 30, 2025 Completion: Dec 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07160270, this observational or N/A phase trial focuses on Peripheral Neuropathies and Waldenstrom Macroglobulinaemia and remains actively recruiting participants. Sponsored by Rigshospitalet, Denmark, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Rigshospitalet, Denmark
Data source: Rigshospitalet, Denmark
For direct contact, visit the study record on ClinicalTrials.gov .